SCHEMBL9694148

SCHEMBL9694148

[O]C(=O)c1ccc([N+](=O)[O-])c2ccccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSB P07858 5/20 0.59
TDP1 Q9NUW8 2/20 0.55
ALDH1A1 P00352 6/20 0.48
AR P10275 2/20 0.46
AKR1C4 P17516 2/20 0.43
AKR1C3 P42330 2/20 0.43
AKR1C2 P52895 2/20 0.43
AKR1C1 Q04828 2/20 0.43
CASP6 P55212 2/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
KDM4E B2RXH2 1/20 0.42
BRD4 O60885 1/20 0.42
LMNA P02545 1/20 0.42
HSP90AA1 P07900 1/20 0.42
MAPT P10636 1/20 0.42
CHRM1 P11229 1/20 0.42
DRD2 P14416 1/20 0.42
ALOX12 P18054 1/20 0.42
ADRA2B P18089 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29475630 0.85 CTSB (0.59) CTSBTDP1ALDH1A1ARAKR1C4
SCHEMBL2778988 0.85 CTSB (0.59) CTSBTDP1ALDH1A1ARAKR1C4
SCHEMBL26656853 0.84 CTSB (0.58) CTSBTDP1ALDH1A1ARAKR1C4
SCHEMBL13110624 0.84 CTSB (0.58) CTSBTDP1ALDH1A1ARAKR1C4
SCHEMBL6815898 0.84 CTSB (0.58) CTSBTDP1ALDH1A1ARAKR1C4
SCHEMBL4440398 0.82 CTSB (0.56) CTSBTDP1ALDH1A1ARAKR1C4
SCHEMBL7788656 0.82 TDP1 (0.80) CTSBTDP1ALDH1A1ARCASP6
SCHEMBL8728039 0.81 CTSB (0.54) CTSBTDP1ALDH1A1ARAKR1C4
SCHEMBL5789105 0.80 AKR1C4 (0.55) CTSBTDP1ALDH1A1AKR1C4AKR1C3
SCHEMBL436389 0.76 ALDH1A1 (0.66) TDP1ALDH1A1KDM4EMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5155113-A Administering 5-fluorouracil and derivatives with pyridine and pyridone derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-10-13 US disclosed
EP-0180188-A2 A composition for increasing the anti-cancer activity of an anti-cancer compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 EP disclosed